Attorney General Raúl Labrador urges consumers in Idaho to verify their eligibility for compensation from a $39.1 million settlement with generic drug manufacturer Apotex. The state joins 50 others in this case, which seeks to address accusations that Apotex conspired to inflate prices and limit competition for certain generic drugs.
The multistate coalition announced last fall that a settlement in principle was reached with Apotex, in addition to a $10 million settlement with Heritage Pharmaceuticals. The agreement with Apotex required signatures from all necessary states and territories, which have now been collected. Consequently, the coalition filed the settlement in the U.S. District Court for the District of Connecticut in Hartford.
The relevant compensation applies to those who purchased generic prescription drugs between May 2009 and December 2019. To determine eligibility, individuals can call 1-866-290-0182 (toll-free), email info@AGGenericDrugs.com, or visit www.AGGenericDrugs.com for a list of drugs involved in the settlements.
Attorney General Labrador emphasized the financial impact on families in Idaho, stating, “When companies conspire to fix prices, real people pay the price—especially Idaho families who rely on affordable prescription drugs. I encourage every Idahoan who purchased generic medications during the covered period to review their eligibility and seek compensation if you qualify."
The settlement resolves allegations against both Apotex and Heritage, who were accused of long-running conspiracies to manipulate prices, reduce competition, and restrain trade in the generic drug market. As part of the agreement, both companies will cooperate in ongoing litigation involving numerous other defendants and will commit to reforms ensuring fair competition and compliance with antitrust laws. They have also agreed to measures preventing future misconduct.